SI9200377A - Process for the preparation of 1-substituted 6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxilic acid, novel intermediate used in this process and process for its preparation - Google Patents

Process for the preparation of 1-substituted 6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxilic acid, novel intermediate used in this process and process for its preparation Download PDF

Info

Publication number
SI9200377A
SI9200377A SI9200377A SI9200377A SI9200377A SI 9200377 A SI9200377 A SI 9200377A SI 9200377 A SI9200377 A SI 9200377A SI 9200377 A SI9200377 A SI 9200377A SI 9200377 A SI9200377 A SI 9200377A
Authority
SI
Slovenia
Prior art keywords
dihydroquinoline
oxo
fluoro
piperazinyl
general formula
Prior art date
Application number
SI9200377A
Other languages
Slovenian (sl)
Inventor
Natasa Zupancic
Martin Barbo
Boris Sket
Pavel Zupet
Original Assignee
Krka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka filed Critical Krka
Priority to SI9200377A priority Critical patent/SI9200377A/en
Priority to HU9302940A priority patent/HUT75319A/en
Priority to PL93301045A priority patent/PL173784B1/en
Priority to CZ932643A priority patent/CZ284715B6/en
Priority to LTIP1558A priority patent/LT3084B/en
Priority to CA 2111181 priority patent/CA2111181A1/en
Priority to RU93054527A priority patent/RU2127270C1/en
Priority to HRP931485 priority patent/HRP931485A2/en
Priority to SK140093A priority patent/SK140093A3/en
Priority to YU76593A priority patent/YU76593A/en
Priority to LV931317A priority patent/LV10863B/en
Priority to AT249793A priority patent/AT401648B/en
Publication of SI9200377A publication Critical patent/SI9200377A/en
Priority to EE9400277A priority patent/EE9400277A/en

Links

Description

Postopek za pripravo l-subst-6-fluoro-4-okso-7-(l-piperazinil)-X,4-dihidrokinoIin3-karboksilne kisline, nov intermediat, uporaben v tem postopku, in postopek za pripravo tega intermediataA process for the preparation of 1-subst-6-fluoro-4-oxo-7- (1-piperazinyl) -X, 4-dihydroquinoline-3-carboxylic acid, a new intermediate useful in this process, and a process for the preparation of this intermediate

Področje tehnike, v katero spada izumFIELD OF THE INVENTION

Predloženi izum je s področja organske kemije in se nanaša na postopek za pripravo bioaktivne spojine l-subst.-6-fluoro-4-okso-7-(l-piperazinil)-l,4-dihidrokinolin-3karboksilne kisline s splošno formulo IIThe present invention relates to the field of organic chemistry and relates to a process for the preparation of the bioactive compound 1-subst.-6-fluoro-4-oxo-7- (1-piperazinyl) -1,4-dihydroquinoline-3-carboxylic acid of general formula II

COOH kjer pomeni Rx nižji alkil, nižji cikloalkil ali 2,4-difluorofenil, na nov intermediat l-subst.-6-fluoro-4-okso-7-(4-subst.-l-piperazinil)-l,4-dihidrokinolin-3-karboksilat borov diacetat s splošno formulo ICOOH where R x is lower alkyl, lower cycloalkyl or 2,4-difluorophenyl, to a new intermediate 1-subst-6-fluoro-4-oxo-7- (4-subst-1-piperazinyl) -1, 4- dihydroquinoline-3-carboxylate boron diacetate of general formula I

AeO OAc \ /AeO OAc \ /

c=oc = o

COOR2 kjer imaCOOR2 where it has

Rx preje navedeni pomen in R2 pomeni nižji alkil ali v danem primeru substituiran fenil, ter na postopek za njegovo pripravo.R x is the aforesaid meaning and R 2 is lower alkyl or optionally substituted phenyl, and a process for preparing it.

Spojine s formulo II se uporabljajo v medicini za zdravljenje vnetnih obolenj. Spekter njihovega delovanja je širok, saj delujejo na gram-pozitivne in gram-negativne bakterije.The compounds of formula II are used in medicine for the treatment of inflammatory diseases. Their spectrum of activity is broad, as they act on both gram-positive and gram-negative bacteria.

Tehnični problemA technical problem

Obstajala je potreba po novem postopku za pripravo bioaktivnih spojin s splošno formulo II, kjer bi lahko izvedli nukleofilno substitucijo atoma halogena na mestu 7 v izhodni spojini 1-substituiranem 6-fluoro-7-halo-4-okso-l,4-dihidrokinolin-3karboksilatu borovem diacetatu s splošno formulo IIIThere was a need for a new process for the preparation of bioactive compounds of general formula II, where nucleophilic substitution of the halogen atom at site 7 in the starting compound 1-substituted 6-fluoro-7-halo-4-oxo-1,4-dihydroquinoline- 3carboxylate of boron diacetate of general formula III

kjer je X F ali CI ter ima R1 preje navedeni pomen, s sekundarnim aminom ob milejših reakcijskih pogojih, kar bi zmanjšalo delež nastalega substitucijskega produkta na mestu 6.wherein XF or CI and R 1 of the yarn has the indicated meaning, with a secondary amine under milder reaction conditions, which would reduce the proportion of the resulting substitution product at site 6.

Stanje tehnikeThe state of the art

Sinteza spojin s splošno formulo II je opisana v številnih patentnih dokumentih, npr. kot substitucija klora na mestu 7 l-alkil-6-fluoro-7-halo-4-okso-l,4-dihidrokinolin-3karboksilne kisline s piperazinom v JP št. 66686/1979 in JP št. 33453/1980, v DE 2840910 in DE 3308909 ter kot reakcija hidrolize alkilestra na mestu 3 l-alkil-6fluoro-7-(l-piperazinil)-4-okso-l,4-dihidrokinolin-3-karboksilne kisline v BE 890223.The synthesis of compounds of general formula II is described in a number of patent documents, e.g. as the substitution of chlorine at the site of 7-alkyl-6-fluoro-7-halo-4-oxo-1,4-dihydroquinoline-3-carboxylic acid by piperazine in JP no. 66686/1979 and JP Nos. 33453/1980, in DE 2840910 and DE 3308909, and as the reaction of hydrolysis of alkyl ester at the site of 3-alkyl-6-fluoro-7- (1-piperazinyl) -4-oxo-1,4-dihydroquinoline-3-carboxylic acid in BE 890223.

Za vse te postopke je značilno, da substitucijska reakcija poteka učinkovito le pri temperaturah nad 100 °C, kar ima za posledico velik odstotek konkurenčne reakcije na mestu 6.All of these processes are characterized by the fact that the substitution reaction proceeds efficiently only at temperatures above 100 ° C, resulting in a large percentage of the competitive reaction at site 6.

V ES 9001782 je opisana nukleofilna substitucija na borovih, aluminijevih in silicijevih kelatih, vendar pa nastalega substitucijskega produkta niso izolirali, temveč so takoj izvedli hidrolizo do bioaktivne spojine. V HU 1505/87 je tudi opisana nukleofilna substitucija atoma halogena na mestu 7 v borovem kelatnem kompleksu, ki poteka pri temperaturah nad 100 °C. Tudi v tem primeru nastalega substitucijskeg produkta niso izolirali, temveč so takoj izvedli hidrolizo.ES 9001782 describes nucleophilic substitution on boron, aluminum and silicon chelates, but did not isolate the resulting substitution product but performed hydrolysis immediately to the bioactive compound. HU 1505/87 also describes the nucleophilic substitution of a halogen atom at site 7 in a boron chelate complex that takes place at temperatures above 100 ° C. Even in this case, the resulting substitution product was not isolated but hydrolyzed immediately.

Opis rešitve tehničnega problemaDescription of solution to a technical problem

Prvi predmet izuma je postopek za pripravo l-subst.-6-fluoro-4-okso-7-(lpiperazinil)-l,4-dihidrokinolin-3-karboksilne kisline s splošno formulo IIThe first object of the invention is a process for the preparation of 1-subst.-6-fluoro-4-oxo-7- (1-piperazinyl) -1,4-dihydroquinoline-3-carboxylic acid of general formula II

kjer pomeni Rj nižji alkil, nižji cikloalkil ali 2,4-difluorofenil, ali njene farmacevtsko sprejemljive kislinske adicijske soli, kot hidroklorida ali laktata, in hidratov, ki ga izvedemo tako, da spojino s splošno formulo Iwherein R1 represents lower alkyl, lower cycloalkyl or 2,4-difluorophenyl, or pharmaceutically acceptable acid addition salts thereof, such as hydrochloride or lactate, and hydrates, which are carried out by the compound of general formula I

kjer imawhere it has

R2 preje navedeni pomen in R2 pomeni nižji alkil ali v danem primeru substituiran fenil, podvržemo alkalni hidrolizi ter po želji dobljeno spojino s splošno formulo II prevedemo v njeno farmacevtsko sprejemljivo kislinsko adicijsko sol, kot hidroklorid ali laktat, ali v hidrate.R 2 is given the above meaning and R 2 is lower alkyl or optionally substituted phenyl, subjected to alkaline hydrolysis, and optionally the resulting compound of general formula II is converted into its pharmaceutically acceptable acid addition salt, such as hydrochloride or lactate, or hydrates.

Alkalno hidrolizo izvedemo v vodnem ali vodno-etanolnem mediju npr. z raztopino alkalijskega hidroksida, kot 10%-nega KOH ali 10%-nega NaOH, pri temperaturi odAlkaline hydrolysis is carried out in an aqueous or aqueous-ethanol medium, e.g. with a solution of alkali hydroxide, such as 10% KOH or 10% NaOH, at a temperature of

50°C do temperature refluksa, prednostno pri temperaturi refluksa reakcijske zmesi.50 ° C to reflux temperature, preferably at reflux temperature of the reaction mixture.

Po nevtralizaciji s kislino, prednostno ocetno kislino, se izloči produkt, ki vsebuje brez dodatnega čiščenja pod 0,5% skupnih nečistot.After neutralization with an acid, preferably acetic acid, a product is eliminated which contains, without further purification, less than 0.5% of the total impurities.

Drugi predmet izuma je nov intermediat, t.j. l-subst.-6-fluoro-4-okso-7-(4-subst.-lpiperazinil)-l,4-dihidrokinolin-3-karboksilat borov diacetat s splošno formulo I, uporaben kot izhodna snov v gornjem postopku za pripravo bioaktivne spojine s splošno formulo II.Another object of the invention is a novel intermediate, i.e. 1-subst.-6-fluoro-4-oxo-7- (4-subst.-piperazinyl) -1,4-dihydroquinoline-3-carboxylate boron diacetate of general formula I, useful as a starting material in the above process for the preparation of bioactive compounds of general formula II.

Še nadaljnji predmet izuma je postopek za pripravo novega intermediata s splošno formulo I, pri katerem v 1-substituiranem 6-fluoro-4-okso-7-halo-l,4-dihidrokinolin3-karboksilatu borovem diacetatu s splošno formulo III izvedemo nukleofilno substitucijo atoma halogena na mestu 7 z 1-substituiranim piperazinom s formuloA further object of the invention is a process for the preparation of a novel intermediate of general formula I in which nucleophilic atom substitution is carried out in 1-substituted 6-fluoro-4-oxo-7-halo-1,4-dihydroquinoline-3-carboxylate boron diacetate of halogen at site 7 with 1-substituted piperazine of formula

coor2 kjer ima R2 preje navedeni pomen.coor 2 where R 2 yarn has the indicated meaning.

Reakcijo izvajamo v organskem topilu, kot piridinu, dimetilsulfoksidu, dimetilformamidu, l-metil-2-pirolidonu, prednostno l-metil-2-pirolidonu, pri temperaturah od 0 °C do 40 °C, prednostno od 25 °C do 30 °C. Pri tej temperaturi v l-metil-2pirolidonu kot topilu poteče reakcija v času od 10 do 15 ur, pri čemer ne nastanejo nobeni stranski produkti in tudi hidroliza borove soli pri tej temperaturi ne poteče. Pri reakcijskih temperaturah nad 40 °C je namreč razgradnja borove soli zaznavna in s povišano temperaturo zelo hitro narašča. Nastala 3-karboksilna kislina kot posledica te razgradnje je mnogo manj reaktivna, saj poteče nukleofilna substitucija pri temperaturah nad 100 °C.The reaction is carried out in an organic solvent such as pyridine, dimethylsulfoxide, dimethylformamide, 1-methyl-2-pyrrolidone, preferably 1-methyl-2-pyrrolidone, at temperatures from 0 ° C to 40 ° C, preferably from 25 ° C to 30 ° C. . At this temperature, the reaction in l-methyl-2-pyrrolidone as a solvent proceeds for 10 to 15 hours, with no by-products produced and no hydrolysis of the boron salt at this temperature. For reaction temperatures above 40 ° C, the decomposition of boron salt is noticeable and increases rapidly with increasing temperature. The resulting 3-carboxylic acid as a result of this degradation is much less reactive as nucleophilic substitution expires at temperatures above 100 ° C.

Izolacija nastale spojine s formulo I je zelo enostavna , saj se pri obaijanju z alkoholom izloči v čisti obliki in dodatno čiščenje ni potrebno.The isolation of the resultant compound of Formula I is very straightforward, since it is eliminated in pure form when treated with alcohol and no further purification is necessary.

Spojino s splošno formulo I uporabimo kot izhodno snov pri pripravi spojine s splošno formulo II, in sicer v izolirani obliki ali pa in situ.The compound of general formula I is used as a starting material in the preparation of the compound of general formula II, either in isolated form or in situ.

Vsi reaktanti so bodisi tržno dostopni ali pa jih lahko dobimo na tukaj opisani način.All reactants are either commercially available or can be obtained as described herein.

Oba postopka v smislu izuma sta pregledno podana z naslednjo reakcijsko shemo, kjer imajo X, Rj in R2 preje navedeni pomen.Both of the processes of the invention are illustrated transparently by the following reaction scheme, wherein X, R 1 and R 2 have the indicated meaning.

AeO OAc AeO OAc H 0 ' N ·· coor2 H 0 'N ·· coor 2 Fs Fs AeO OAc y °- ? 1 H IIAeO OAc y ° - ? 1 H II 0'* χΥ 0 '* χΥ 0 .0=0 0 .0 = 0 Hi m Hi m COOR2 COOR2 Ri I R and I

“V R, tt VR, tt

Izum natančneje opisujemo, nikakor pa ne omejujemo z naslednjimi primeri.The invention is described in more detail, but in no way limited by the following examples.

Primer 1 l-ciklopropil-6-fluoro-4-okso-7-(4-karboetoksi-l-piperazinil)-l,4-dihidrokinolin-3-karboksilat borov diacetat g (0,0244· molov) l-ciklopropil-6-fluoro-4-okso-7-kloro-l,4-dihidrokinolin-3karboksilata borovega diacetata in 15,44 g (0,0977 molov) l-karboetoksipiperazina suspendiramo v 40 ml l-metil-2-pirolidona in mešamo pri temperaturi 30 °C 12 ur. Po končani reakciji dodamo k reakcijski zmesi 60 ml absolutnega etanola in mešamo pri sobni temperaturi 2 uri. Izločeno oborino odnučamo, speremo z etanolom in posušimo v vakuumu pri 80 °C. Filtrat ohladimo na 0 do 5 °C in izločeno oborino odnučamo, suspendiramo v zmes l-metil-2-pirolidona/etanola (2:1) in maceriramo 2 uri, odnučamo in posušimo. Produkta združimo. Tako dobimo 10,75 g (83%) kromatografsko čistega l-ciklopropil-6-fluoro-4-okso-7-(4-karboetoksi- 1piperazinil)-l,4-dihidrokinolin-3-karboksilata borovega diacetata s tal. 235 do 240°C.Example 1 1-Cyclopropyl-6-fluoro-4-oxo-7- (4-carboethoxy-1-piperazinyl) -1,4-dihydroquinoline-3-carboxylate boron diacetate g (0.0244 · mol) 1-cyclopropyl-6 -fluoro-4-oxo-7-chloro-1,4-dihydroquinoline-3-carboxylate of boron diacetate and 15.44 g (0.0977 mol) of 1-carboethoxypiperazine were suspended in 40 ml of 1-methyl-2-pyrrolidone and stirred at 30 ° C 12 hours After completion of the reaction, 60 ml of absolute ethanol was added to the reaction mixture and stirred at room temperature for 2 hours. The precipitated precipitate was filtered off, washed with ethanol and dried in vacuo at 80 ° C. The filtrate was cooled to 0 to 5 ° C and the precipitated precipitate was filtered off, suspended in 1-methyl-2-pyrrolidone / ethanol (2: 1) and macerated for 2 hours, filtered off and dried. We combine products. There was thus obtained 10.75 g (83%) of chromatographically pure 1-cyclopropyl-6-fluoro-4-oxo-7- (4-carboethoxy-1piperazinyl) -1,4-dihydroquinoline-3-carboxylate pine diacetate from m.p. 235 to 240 ° C.

Spektroskopski podatki:Spectroscopic data:

*H NMR spekter (CF3COOH, TMS) (posneto na 300 MHz instrumentu):* H NMR spectrum (CF 3 COOH, TMS) (recorded on a 300 MHz instrument):

^cH2(cikioPropii) ~ (m> J=8Hz, 2H), 5CH3 = 1.30 (t, J=8Hz, 3H), 5CH2^ciklopropi])=^ cH2 (cyclo P ropii) ~ ( m > J = 8Hz, 2H), 5 CH3 = 1.30 (t, J = 8Hz, 3H), 5 CH2 ^ cyclopropes] ) =

1.52 (m, J=8Hz, 2H), 5CH3 = 2.03 (s, 6H), 6CH2(piperazinil^ = 3.42 (m, 4H), ^CH2(.piperazinilj = 3.74 (m, 4H), §CH(ciklopropil) = 3.73 (m, J=8Hz, IH), S0CH2 = 4.2 (q, J=8Hz, 2H), δΗ8 = 7-48 PPm J=8Hz, IH), δΗ5 = 8.08 (d, J=14.3Hz, IH), δΗ2= 9.0 ppm (s, IH).1.52 (m, J = 8Hz, 2H), 5 CH3 = 2.03 (s, 6H), 6 CH2 (piperazinyl = 3.42 (m, 4H), ^ CH2 ( . Piperazinyl j = 3.74 (m, 4H), §CH (cyclopropyl) = 3.73 (m, J = 8Hz, 1H), S 0CH2 = 4.2 (q, J = 8Hz, 2H), δ Η8 = 7-48 PP m J = 8Hz, 1H), δ Η5 = 8.08 (d , J = 14.3Hz, 1H), δ Η 2 = 9.0 ppm (s, 1H).

IR spekter:IR spectrum:

1700,1630,1480,1370,1275,1240,1060,960 cm’1.1700,1630,1480,1370,1275,1240,1060,960 cm ' 1 .

Primer 2 l-etiI-6-fluoro-4-okso-7-(4-karboetoksi-l-piperazmil)-l,4-dihidrokinolin-3-karboksilat borov diacetatExample 2 1-Ethyl-6-fluoro-4-oxo-7- (4-carboethoxy-1-piperazinyl) -1,4-dihydroquinoline-3-carboxylate boron diacetate

2,37 g (0,006 molov) l-etil-6-fluoro-4-okso-7-kloro-l,4-dihidrokinolin-3-karboksilata borovega diacetata in 3,78 g (0,024 molov) l-karboetoksipiperazina suspendiramo v2.37 g (0.006 mol) of 1-ethyl-6-fluoro-4-oxo-7-chloro-1,4-dihydroquinoline-3-carboxylate of boron diacetate and 3.78 g (0.024 mol) of 1-carboethoxypiperazine were suspended in

9,5 ml l-metil-2-pirolidona in mešamo 9 ur pri 30 °C. Po končani reakciji dodamo reakcijski zmesi 19 ml absolutnega etanola in mešamo 2 uri pri sobni temperaturi.9.5 ml of 1-methyl-2-pyrrolidone and stirred at 30 ° C for 9 hours. After completion of the reaction, 19 mL of absolute ethanol was added to the reaction mixture and stirred at room temperature for 2 hours.

Izločeni produkt odnučamo, speremo z etanolom in posušimo v vakuumu pri 80 °C. Tako dobimo 2,7 g (87%) l-etil-6-fluoro-4-okso-7-(4-karboetoksi-l-piperazinil)-l,4dihidrokinolin-3-karboksilata borovega diacetata s tal. 235 do 238 °C.The separated product was filtered off, washed with ethanol and dried in vacuo at 80 ° C. 2.7 g (87%) of 1-ethyl-6-fluoro-4-oxo-7- (4-carboethoxy-1-piperazinyl) -1,4-dihydroquinoline-3-carboxylate of boron diacetate were obtained from m.p. 235 to 238 ° C.

Spektroskopski podatki:Spectroscopic data:

Ή NMR spekter (CF3COOH, TMS) (posneto na 60 MHz instrumentu):Ή NMR spectrum (CF 3 COOH, TMS) (recorded on a 60 MHz instrument):

5CH3 = 1.53 (t, J=7Hz, 3H), 5CH3 = 1.97 (t, J=7Hz, 3H), 5CH3 = 2.4 (s, 6H), ^CH2(piperazinil) ~ ^NCH2 ~ fa’ J=7Hz, 2H), 5QCH2 = 5.03 (q, J=7Hz,5 CH3 = 1.53 (t, J = 7Hz, 3H), 5 CH3 = 1.97 (t, J = 7Hz, 3H), 5 CH3 = 2.4 (s, 6H), ^ CH2 (piperazinyl) ~ ^ NCH2 ~ fa 'J = 7Hz, 2H), 5 QCH2 = 5.03 (q, J = 7Hz,

2H), δΗ8 = 7.7 (d, J=6Hz, IH), δΗ5 = 8.4 (d, J=12Hz, IH), δΗ2 = 9.6 ppm (s, IH).2H), δ Η8 = 7.7 (d, J = 6Hz, 1H), δ Η5 = 8.4 (d, J = 12Hz, 1H), δ Η2 = 9.6 ppm (s, 1H).

19F NMR spekter (CF3COOH, CFC13) (posneto na 60 MHz instrumentu): δρ= -114.0 ppm (dd, J=12Hz; 6Hz). 19 F NMR spectrum (CF 3 COOH, CFC1 3 ) (recorded on a 60 MHz instrument): δ ρ = -114.0 ppm (dd, J = 12Hz; 6Hz).

IR spekter:IR spectrum:

1700,1635,1490,1375,1285,1240,1060,970 cm4.1700,1635,1490,1375,1285,1240,1060,970 cm 4 .

Primer 3 l-ciklopropil-6-fluoro-4-okso-7-(l-piperazinil)-l,4-dihidrokinolin-3-karboksilna kislina g (0,0188 molov) l-ciklopropil-6-fluoro-4-okso-7-(4-karboetoksi-l-piperazinil)l,4-dihidrokinolin-3-karboksilata borovega diacetata suspendiramo v 187 ml 10%nega KOH in segrevamo pri temperaturi refluksa 1,5 ure. Nato reakcijsko zmes ohladimo na sobno temperaturo in z ocetno kislino uravnamo pH na 7,2 do 7,4. Reakcijsko zmes mešamo še 30 minut, oborino odnučamo, speremo z vodo in posušimo. Tako dobimo 5,95 g (96%) l-ciklopropil-6-fluoro-4-okso-7-(l-piperazinil)-l,4dihidrokinolin-3-karboksilne kisline s tal. 258 do 263 °C.Example 3 1-Cyclopropyl-6-fluoro-4-oxo-7- (1-piperazinyl) -1,4-dihydroquinoline-3-carboxylic acid g (0.0188 mol) 1-cyclopropyl-6-fluoro-4-oxo -7- (4-Carboethoxy-1-piperazinyl) 1,4-dihydroquinoline-3-carboxylate boron diacetate was suspended in 187 ml of 10% KOH and heated at reflux for 1.5 hours. The reaction mixture was then cooled to room temperature and the pH adjusted to 7.2 to 7.4 with acetic acid. The reaction mixture was stirred for another 30 minutes, the precipitate was filtered off, washed with water and dried. 5.95 g (96%) of 1-cyclopropyl-6-fluoro-4-oxo-7- (1-piperazinyl) -1,4-dihydroquinoline-3-carboxylic acid are thus obtained, m.p. 258 to 263 ° C.

Primer 4 l-ciklopropil-6-fluoro-4-okso-7-(l-piperazinil)-l,4-dihidrokinolin-3-karboksilna kislina hidroklorid monohidrat g (0,0056 molov) l-ciklopropil-6-fluoro-4-okso-7-(4-karboetoksi-l-piperazinil)-l,4dihidrokinolin-3-karboksilata borovega diacetata suspendiramo v 56 ml 10%-negaExample 4 1-Cyclopropyl-6-fluoro-4-oxo-7- (1-piperazinyl) -1,4-dihydroquinoline-3-carboxylic acid hydrochloride monohydrate g (0.0056 mol) 1-cyclopropyl-6-fluoro-4 -oxo-7- (4-carboethoxy-1-piperazinyl) -1,4-dihydroquinoline-3-carboxylate of boron diacetate was suspended in 56 ml of 10%

KOH in segrevamo pri temperaturi refluksa 1,5 ure. Po končani reakciji dodamo 8 ml koncentrirane HC1 in segrevamo 30 minut pri temperaturi 80 °C. Nato reakcijsko zmes ohladimo na sobno temperaturo, dodamo 14 ml etanola, mešamo še 30 minut, izločeno oborino odnučamo in izperemo z vodo ter posušimo do konstantne mase. Tako dobimo 1,98 g (92%) l-ciklopropil-6-fluoro-4-okso-7-(l-piperazinil)-l,4dihidrokinolin-3-karboksilna kisline hidroklorida monohidrata s tal. 282 do 288 °C.KOH and heated at reflux temperature for 1.5 hours. After completion of the reaction, 8 ml of concentrated HCl was added and heated at 80 ° C for 30 minutes. The reaction mixture was then cooled to room temperature, 14 ml of ethanol was added, stirred for a further 30 minutes, the precipitate was filtered off and washed with water and dried to constant weight. 1.98 g (92%) of 1-cyclopropyl-6-fluoro-4-oxo-7- (1-piperazinyl) -1,4-dihydroquinoline-3-carboxylic acid hydrochloride monohydrate are thus obtained from m.p. 282 to 288 ° C.

Primer 5 l-etil-6-fluoro-4-okso-7-(l-piperazinil)-l,4-dihidrokinolin-3-karboksilna kislinaExample 5 1-Ethyl-6-fluoro-4-oxo-7- (1-piperazinyl) -1,4-dihydroquinoline-3-carboxylic acid

1,04 g (0,002 mola) l-etil-6-fluoro-4-okso-7-(4-karboetoksi-l-piperazinil)-l,4dihidrokinolin-3-karboksilata borovega diacetata suspendiramo v 16 ml 10%-nega KOH in 12 ml etanola ter segrevamo pri temperaturi refluksa zmesi 11 ur. Nato zmes ohladimo na 15 °C in uravnamo pH na 7,2 do 7,4 s 15% HC1 in mešamo pri omenjeni temperaturi še 30 minut. Izločeno oborino odnučamo, speremo z vodo in posušimo do konstantne mase v vakuumskem sušilniku pri 100 °C. Tako dobimo 0,6 g (93%) l-etil-6-fluoro-4-okso-7-(l-piperazinil)-l,4-dihidrokinolin-3-karboksilne kisline s tal. 218 do 221 °C.1.04 g (0.002 mol) of 1-ethyl-6-fluoro-4-oxo-7- (4-carboethoxy-1-piperazinyl) -1,4-dihydroquinoline-3-carboxylate of boron diacetate were suspended in 16 ml of 10% KOH and 12 ml of ethanol and heated at reflux temperature for 11 hours. The mixture was then cooled to 15 ° C and the pH adjusted to 7.2 to 7.4 with 15% HCl and stirred at this temperature for another 30 minutes. The precipitated precipitate was filtered off, washed with water and dried to constant weight in a vacuum oven at 100 ° C. 0.6 g (93%) of 1-ethyl-6-fluoro-4-oxo-7- (1-piperazinyl) -1,4-dihydroquinoline-3-carboxylic acid are obtained from m.p. 218 to 221 ° C.

Claims (7)

PATENTNI ZAHTEVKIPATENT APPLICATIONS 1. Postopek za pripravo l-subst.-6-fluoro-4-okso-7-(l-piperazinil)-l,4dihidrokinolin-3-karboksilne kisline s splošno formulo II kjer pomeni Rj nižji alkil, nižji cikloalkil ali 2,4-difluorofenil, ali njene farmacevtsko sprejemljive kislinske adicijske soli, kot hidroklorida ali laktata, in hidratov, označen s tem, da spojino s splošno formulo IA process for the preparation of 1-subst.-6-fluoro-4-oxo-7- (1-piperazinyl) -1,4-dihydroquinoline-3-carboxylic acid of the general formula II wherein R 1 is lower alkyl, lower cycloalkyl or 2,4 -difluorophenyl, or its pharmaceutically acceptable acid addition salts, such as hydrochloride or lactate, and hydrates, characterized in that the compound of general formula I COOEt, kjer ima Rt preje navedeni pomen in R2 pomeni nižji alkil ali v danem primeru substituiran fenil, podvržemo alkalni hidrolizi in po želji dobljeno spojino s splošno formulo II pretvorimo v njeno farmacevtsko sprejemljivo kislinsko adicijsko sol, kot hidroklorid ali laktat, in hidrate.COOEt, wherein R t is of the foregoing meaning and R 2 is lower alkyl or optionally substituted phenyl, is subjected to alkaline hydrolysis and optionally converted to a pharmaceutically acceptable acid addition salt thereof, such as hydrochloride or lactate, and hydrates . 2. l-subst.-6-fluoro-4-okso-7-(4-subst.-l-piperazinil)-l,4-dihidrokinolin-3-karboksilat borov diacetat s splošno formulo I kjer pomeni R1 nižji alkil, nižji cikloalkil ali 2,4-difluorofenil in R2 nižji alkil ali v danem primeru substituiran fenil.2. 1-Subst-6-fluoro-4-oxo-7- (4-subst-1-piperazinyl) -1,4-dihydroquinoline-3-carboxylate boron diacetate of general formula I wherein R 1 is lower alkyl, lower cycloalkyl or 2,4-difluorophenyl and R2 lower alkyl or optionally substituted phenyl. 3. Postopek za pripravo l-subst.-6-fluoro-4-okso-7-(4-subst.-l-piperazinil)-l,4dihidrokinolin-3-karboksilata borovega diacetata s splošno formulo I kjer pomeni Rx nižji alkil, nižji cikloalkil ali 2,4-difluorofenil in R2 nižji alkil ali v danem primeru substituiran fenil, označen s tem, da v 1-substituiranem 6-fluoro-4-okso-7-halo-l,4-dihidrokinolin-3karboksilatu borovem diacetatu s splošno formulo III kjer je X F ali Cl ter ima Rj preje navedeni pomen, izvedemo nukleofilno substitucijo atoma halogena na mestu 7 z 1-substituiranim piperazinom s formuloA process for the preparation of 1-subst.-6-fluoro-4-oxo-7- (4-subst-1-piperazinyl) -1,4-dihydroquinoline-3-carboxylate of boron diacetate of the general formula I wherein R x is lower alkyl , lower cycloalkyl or 2,4-difluorophenyl and R 2 lower alkyl or optionally substituted phenyl, characterized in that in 1-substituted 6-fluoro-4-oxo-7-halo-1,4-dihydroquinoline-3-carboxylate boron diacetate of general formula III wherein XF or Cl and Rj having the foregoing meaning, nucleophilic substitution of the halogen atom at site 7 with 1-substituted piperazine of formula Η kjer ima R2 preje navedeni pomen.Η where R 2 yarn has the indicated meaning. 4. Postopek po zahtevku 1, označen s tem, da ga izvajamo v vodnem ali etanolnovodnem mediju.A process according to claim 1, characterized in that it is carried out in aqueous or ethanol-water medium. 5. Postopek po zahtevku 1, označen s tem, da ga izvajamo pri temperaturi od 50°C do temperature refluksa reakcijske zmesi.A process according to claim 1, characterized in that it is carried out at a temperature from 50 ° C to the reflux temperature of the reaction mixture. 6. Postopek po zahtevku 3, označen s tem, da ga izvedemo v organskem topilu, kot piridinu, dimetilsulfoksidu, dimetilformamidu, l-metil-2-pirolidonu, prednostno l-metil-2-pirolidonu.Process according to claim 3, characterized in that it is carried out in an organic solvent such as pyridine, dimethylsulfoxide, dimethylformamide, 1-methyl-2-pyrrolidone, preferably 1-methyl-2-pyrrolidone. 7. Postopek po zahtevku 3, označen s tem, da ga izvajamo pri temperaturah od 0 °C do 40 °C, prednostno od 20 do 30 °C.The method of claim 3, characterized in that it is carried out at temperatures from 0 ° C to 40 ° C, preferably from 20 to 30 ° C.
SI9200377A 1992-12-11 1992-12-11 Process for the preparation of 1-substituted 6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxilic acid, novel intermediate used in this process and process for its preparation SI9200377A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SI9200377A SI9200377A (en) 1992-12-11 1992-12-11 Process for the preparation of 1-substituted 6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxilic acid, novel intermediate used in this process and process for its preparation
HU9302940A HUT75319A (en) 1992-12-11 1993-10-18 1,4-dihydroquinoline-3-carboxylic acid derivatives and process for producing them
PL93301045A PL173784B1 (en) 1992-12-11 1993-11-12 Method of obtaining 1-substituted 6-fluoro-4-oxo-7-/1-piperazinyl/-1,4-dihydroquinoline-3-carboxylic acid, novel intermediate useful in that method and method of obtaining such intermediate product
CZ932643A CZ284715B6 (en) 1992-12-11 1993-12-06 Process for preparing 6-fluoro-4-oxo-7-(1-piperazinyl)-1,4- dihydroquinoline-3-carboxylic acid being substituted in position 1 and starting substance for preparing thereof
LTIP1558A LT3084B (en) 1992-12-11 1993-12-07 Process for preparing 1-substituted-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid,a novel intermediate useful in said process, and a process for preparing said intermediate
CA 2111181 CA2111181A1 (en) 1992-12-11 1993-12-10 Process for preparing 1-substituted-6-fluoro-4-oxo-7- (1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid, a novel intermediate useful in said process, and a process for preparing said intermediate
RU93054527A RU2127270C1 (en) 1992-12-11 1993-12-10 Method of synthesis of 1-substituted-6-fluoro-4-oxo-7-(1- -piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid, 1-substituted-6-fluoro-4-oxo-7-(4-substituted-1-piperazinyl)- -1,4-dihydroquinoline-3-carboxylate-boron-diacetate and a method of its synthesis
HRP931485 HRP931485A2 (en) 1992-12-11 1993-12-10 Process for the preparation of 1-supst.-fluoro-4-oxo-7-(1-piperazinyl)-1,4-hydroquinoline-3-carbonic acid, new rmediate, used in that process and a process for the aration of that intermediate
SK140093A SK140093A3 (en) 1992-12-11 1993-12-10 Method of preparation 1-substituted 6-flourine-4-oxo-7- (1-piperazinyle)-1,4-dihydroquinoline-3-carboxylic acid and intermediate products
YU76593A YU76593A (en) 1992-12-11 1993-12-10 1-SUPST.-6-FLUORO-4-OXO-7- (1-PIPERAZINYL) -1,4-DIHYDROHINOLINES-3-CARBOXYLIC ACIDS, A NEW INTERMEDIATE USED IN THIS PROCEDURE AND A PROCEDURE FOR OBTAINING INTERMEDIATE
LV931317A LV10863B (en) 1992-12-11 1993-12-10 Process for preparing 1-substituted-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid, a novel intermediate useful in said process, and a process for preparing said intermediate
AT249793A AT401648B (en) 1992-12-11 1993-12-10 Process for the preparation of 1-subst.-6-fluoro-4-oxo-7- (1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid, novel intermediate for use in this process and process for the preparation of this intermediate
EE9400277A EE9400277A (en) 1992-12-11 1994-11-17 Process for the preparation of 1-substituted-6-fluoro-4-oxo-7- (1-piperazinyl) -1,4-dihydroquinoline-3-carboxylic acid, intermediate used in the process and method for its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI9200377A SI9200377A (en) 1992-12-11 1992-12-11 Process for the preparation of 1-substituted 6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxilic acid, novel intermediate used in this process and process for its preparation

Publications (1)

Publication Number Publication Date
SI9200377A true SI9200377A (en) 1994-06-30

Family

ID=20431064

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9200377A SI9200377A (en) 1992-12-11 1992-12-11 Process for the preparation of 1-substituted 6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxilic acid, novel intermediate used in this process and process for its preparation

Country Status (13)

Country Link
AT (1) AT401648B (en)
CA (1) CA2111181A1 (en)
CZ (1) CZ284715B6 (en)
EE (1) EE9400277A (en)
HR (1) HRP931485A2 (en)
HU (1) HUT75319A (en)
LT (1) LT3084B (en)
LV (1) LV10863B (en)
PL (1) PL173784B1 (en)
RU (1) RU2127270C1 (en)
SI (1) SI9200377A (en)
SK (1) SK140093A3 (en)
YU (1) YU76593A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452888B2 (en) * 2002-03-27 2008-11-18 Glaxo Group Limited Quinoline derivatives and their use as 5-ht6 ligands

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE444566B (en) 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-DIALKYLAMINE-6-HALOGEN-4-OXO-1,4-DIHYDROQINOLINE-3-CARBOXYLIC ACID, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATION OF THEREOF
DE2747357A1 (en) 1977-10-21 1979-04-26 Bayer Ag SUBSTITUTED PYRIMIDINYL (THIONO) (THIOL) PHOSPHOR (PHOSPHON) ACID ESTERS OR. -ESTERAMIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS INSECTICIDES AND ACARICIDES
JPS5533453A (en) 1978-08-31 1980-03-08 Dainippon Pharmaceut Co Ltd Preventive and remedy for infectious disease of fish
JPS5762259A (en) 1980-09-05 1982-04-15 Kyorin Pharmaceut Co Ltd Preparation of substituted quinolinecarboxylic acid derivative
DE3308909A1 (en) 1983-03-12 1984-09-13 Bayer Ag, 5090 Leverkusen BACTERICIDALS BASED ON CHINOLONIC CARBONIC ACID
DE8812756U1 (en) 1988-09-22 1988-12-01 Weinschlauch Hemue Weinhandel Gmbh, 4000 Duesseldorf, De

Also Published As

Publication number Publication date
CZ284715B6 (en) 1999-02-17
LV10863A (en) 1995-10-20
HU9302940D0 (en) 1993-12-28
HUT75319A (en) 1997-05-28
ATA249793A (en) 1996-03-15
RU2127270C1 (en) 1999-03-10
LV10863B (en) 1996-08-20
HRP931485A2 (en) 1995-04-30
PL301045A1 (en) 1994-06-13
YU76593A (en) 1996-07-24
LTIP1558A (en) 1994-06-15
LT3084B (en) 1994-11-25
PL173784B1 (en) 1998-04-30
EE9400277A (en) 1996-04-15
CZ264393A3 (en) 1994-07-13
CA2111181A1 (en) 1994-06-12
SK140093A3 (en) 1994-11-09
AT401648B (en) 1996-10-25

Similar Documents

Publication Publication Date Title
CA1340285C (en) Novel quinolonecarboxylic acid derivatives having at 7-position a piperidin-1-yl substituent
JPS59130880A (en) 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7- (alkyl-1-piperazinyl)quinoline-3-carboxylic acids, manufacture and antibacterial
HU199821B (en) Process for production of derivatives of in 8 position substituated quinoline carbonic acid and medical compositions containing them
CA1339373C (en) 6-7-disubstituted 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-c arboxylic acids
DE3135125C2 (en)
IE840443L (en) Quinolonecarboxylic acids
SI9200377A (en) Process for the preparation of 1-substituted 6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxilic acid, novel intermediate used in this process and process for its preparation
SU1321376A3 (en) Method of producing derivatives of quinolinecarboxylic acid
CA2199645C (en) Methods for the manufacture of quinolone carboxylic acids derivatives and intermediates thereof
CA2504796A1 (en) Polymorphs of pantoprazole sodium salt and process for the preparation thereof
FI84072C (en) Intermediate for the production of norfloxacin and process for its preparation
JPH08506832A (en) Method for producing quinolinecarboxylic acid and its derivative
SI9300192A (en) Process for preparation of 1-subs.-6-fluoro-4-okso-7-(1-piperazinil or 4-subst.-1-piperazinil)-1,4-dihydroquinolin-3-carboxylic acid, novel intermediate and process for thereof
AT397385B (en) METHOD FOR PRODUCING CHINOLINE CARBONIC ACID DERIVATIVES
CN111989314B (en) Method for hydrolyzing quinolone formate
JPH01128982A (en) Synthesis of benzo(ij)quinolidine-2-carboxylic acid derivative
CA1340561C (en) Process for preparing ciprofloxacine
KR870000894B1 (en) Process for preparing quinolone carboxylic acids
US4301288A (en) Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid
FI91749C (en) Process for the preparation of quinoline carboxylic acid derivatives
LT3274B (en) Process for preparing 1-substituted 6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid
CS265229B2 (en) Making of intermediate for amifloxacine production
JPS5925795B2 (en) Pyrido[2,3-c]acridine-1-hydroxy-2-carboxylic acid and its derivatives and their production method
KR950001013B1 (en) Process for the preparation of quinolone derivatives
KR870000893B1 (en) Process for preparing quinolone carboxylic acids